Controversy in Tranexamic Acid Administration Route Continues: Commentary on an article by Zeng Yi, MD, et al.: "Tranexamic Acid Administration in Primary Total Hip Arthroplasty: A Randomized Controlled Trial of Intravenous Combined with Topical Versus Single-Dose Intravenous Administration".
Second Orthopaedic Department, National and Kapodistrian University of Athens Medical School, Konstantopouleio General Hospital, Athens, Greece george.babis@gmail.com.
George C
GC
Babis
D061605:Administration, Intravenous; D000287:Administration, Topical; D000933:Antifibrinolytic Agents / Q000008:administration & dosage; D019644:Arthroplasty, Replacement, Hip; D016063:Blood Loss, Surgical; D001803:Blood Transfusion; D006801:Humans; D019106:Postoperative Hemorrhage / Q000188:drug therapy; D014148:Tranexamic Acid / Q000008:administration & dosage*
D000933:Antifibrinolytic Agents; D014148:Tranexamic Acid